Cue Health Serves as Preferred Testing Provider for the 2022 McDonald's All American Games
Cue® helps the nation's premiere high school basketball showcase return to in-person action
Cue's test uses molecular nucleic acid amplification technology (NAAT), providing lab-quality results directly to a user's connected mobile device in about 20 minutes. The test can detect all known COVID-19 variants of concern and can be used on adults and children (age 2 years and over for OTC/home use and under 2 years for professional use), with or without symptoms.
"The
Last month, Cue announced a partnership with former McDonald's All American and three-time NBA All-Star
The
Cue's COVID-19 OTC Test is available at shop.cuehealth.com and can be purchased a la carte or through its Cue+™ membership model. In addition to the most accurate at-home COVID-19 test available, Cue+ offers benefits such as access to 24/7 virtual care, prescription services, same-day delivery in select markets, and supervised testing by virtual proctor, which meets
*Based on clinical study results submitted to FDA for other EUA molecular home tests.
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements". The words, without limitation, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including those related to the expected future diagnostic test menu and the factors discussed in the "Risk Factors" section of the Form 10-Q dated
These products have not been FDA cleared or approved; but have been authorized by FDA under an Emergency Use Authorization (EUA). These products have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cue-health-serves-as-preferred-testing-provider-for-the-2022-mcdonalds-all-american-games-301511588.html
SOURCE
MEDIA INQUIRIES: press@cuehealth.com